選項

處方審核助手

{:__('collect %s',處方審核助手)}

輔助藥師快速識別處方中的潛在藥物相互作用、劑量異常及禁忌症,提升用藥安全。

提示內容 複製 複製

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male with a history of hypertension and mild renal insufficiency, currently prescribed amoxicillin, ibuprofen, and warfarin. Focus on analyzing the bleeding risk associated with combining ibuprofen and warfarin, evaluate the necessity of dose adjustment for amoxicillin in the context of renal insufficiency, and identify any other potential drug interactions or contraindications. Finally, provide clear medication recommendations or adjustment plans.

複製 複製

請作為資深臨床藥師,對以下患者處方進行合規性審查:患者為65歲男性,既往有高血壓和輕度腎功能不全病史,當前開具了阿莫西林、布洛芬及華法林。請重點分析布洛芬與華法林聯用對出血風險的影響,評估阿莫西林在腎功能不全情況下的劑量調整必要性,並指出是否存在其他潛在的藥物相互作用或禁忌症,最後給出明確的用藥建議或調整方案。

複製 複製
評論 (0)
0/300

推薦

處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.
處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.
處方審核助手
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.
處方審核助手
Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.
處方審核助手
Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.
處方審核助手
Act as a senior clinical pharmacist responsible for real-time compliance review of prescriptions within an electronic medical record system. Based on the patient's current diagnosis, medical history, allergies, and concurrent medications, strictly cross-reference the latest clinical guidelines and drug labels to analyze the appropriateness of indications, dosages, routes of administration, and duration for each drug in the prescription. Prioritize identifying potential drug-drug interactions, drug-disease contraindications, or off-label use risks. If potential issues are found, clearly specify the risk type and provide evidence-based alternative solutions or adjustment recommendations; if the prescription is compliant, confirm its safety. Finally, output a structured, professional audit opinion for clinical decision support, without any introductory remarks or explanatory text.
OR